Condition
Oral Leukoplakia clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Oral Leukoplakia clinical trials that are recruiting, at sites in 4 countries (most in Egypt (3), United States (1), Italy (1)). 1 was first registered in the last 30 days. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1New in 30 days
- 4Countries
Newest Oral Leukoplakia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Salivary IL-8 and Serum IL-6 as Biomarkers to Distinguish Oral Premalignant Disorders in Smokers and Never-Smokers | — | Cairo | Recruiting | Nov 4, 2026 |
| Topical and oral metformin to prevent or shrink oral leukoplakia | Phase 2 | Cairo | Recruiting | Feb 4, 2026 |
| Topical Coenzyme Q10 versus Curcumin for oral leukoplakia treatment | — | Alexandria | Recruiting | Jan 12, 2026 |
| Using Optical Coherence Tomography to Diagnose Oral Cancer | — | Palermo | Recruiting | Mar 20, 2024 |
| Combination treatment of pioglitazone and metformin for high-risk oral lesions | Phase 2 | Minneapolis, Minnesota and 1 other locations | Recruiting | Feb 14, 2023 |
| Predicting cancer risk in oral leukoplakia using MAGE-A markers | — | Erlangen | Recruiting | Jun 5, 2019 |
All recruiting trials (6)
-
Salivary IL-8 and Serum IL-6 as Biomarkers to Distinguish Oral Premalignant Disorders in Smokers and Never-Smokers
This study tests whether salivary IL-8 and blood IL-6 can help tell apart adults with oral premalignant conditions from those with healthy mouths, and whether smoking influences these markers.
-
Topical and oral metformin to prevent or shrink oral leukoplakia
This study will test whether using metformin both as a mouth application and as oral tablets can shrink or prevent early oral leukoplakia in adults with mild-to-moderate dysplasia.
-
Topical Coenzyme Q10 versus Curcumin for oral leukoplakia treatment
This trial will test whether applying Coenzyme Q10 or curcumin gels directly to homogeneous oral leukoplakia lesions helps shrink or stabilize them in patients who do not need surgery.
-
Using Optical Coherence Tomography to Diagnose Oral Cancer
This study is testing if a special imaging technique called Optical Coherence Tomography can help doctors find oral cancer earlier and more accurately in patients with potentially harmful mouth conditions.
-
Combination treatment of pioglitazone and metformin for high-risk oral lesions
This study is testing if a combination of two medications, pioglitazone and metformin, can help reduce the size and severity of precancerous oral lesions in patients with oral leukoplakia.
-
Predicting cancer risk in oral leukoplakia using MAGE-A markers
This study is trying to see if certain markers in people with oral leukoplakia can help predict their risk of developing oral cancer.
Related topics
Quick answers
How many Oral Leukoplakia clinical trials are recruiting right now?
6, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Egypt (3 trials), United States (1 trial), Italy (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.